Record overview
Status and phase
Status: UNKNOWN
Phase: PHASE1, PHASE2
Sponsor: Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
Condition: Clear-cell Metastatic Renal Cell Carcinoma, Bone Metastases
NCT02880943
Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL)
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Unknown Status Signal
Timeline signals: stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal
Results signal: Low Signal
Operational burden: None
Stopped reason
Context when available
No stop reason available in the current public record.